This is an interactive Newsletter. As you scroll over the Newsletter, if the hand turns into a pointing finger, that means – with a click of your mouse – your browser will open to the website which relates to that item.
30-Patient Limit

After years of efforts to relieve physicians, patients and their families of this restriction and allow lifesaving treatment to those in need, on 12/8/2006 both the House and the Senate passed a bill to raise the limit to 100, with some conditions. This Bill, soon to be law, states that after one year a practitioner may submit a notification of the “intent” and “need” to treat up to 100 patients. This is a great step forward. Although the need for any limit, at all, is not supported by the current body of evidence, this is a welcome change.

Details of this new legislation can be found on our 30-Patient Limit page:

The timing couldn’t be better. This news coincides with a NAABT patient awareness/out-reach program kicking off in Detroit, Philadelphia, and New York City this week. The aim is to create awareness of the Buprenorphine Treatment option and to communicate that there is hope for the many that feel trapped, especially at this time of the year. (See ad samples.)

Patient/Physician Matching System. 680 physicians nationwide have already registered and are accepting patients now. Our confidential online patient matching system is a non-intimidating quick, free and easy way to match a patient seeking treatment with a physician certified to prescribe buprenorphine. Many of the 1,593 patients who have registered since the National launch on September 1st, have been contacted by a physician the very same day.

In other parts of the country, we still need participating physicians to offer treatment to those in need in their communities. Surprisingly, in some areas there are physicians willing to treat, while patients suffering with opioid addiction are unaware of the treatment. As word spreads across the country more and more patients will “get their lives back” and put their addiction in remission.

Patients seeking treatment can register securely,
anonymously and confidentially at:

See the current national map of patients seeking treatment.

See the current national map of participating certified physicians.
(Size of circle indicates 50 mile effective service area.)

Place this, or other versions of this button, on your website!
30-Patient Petition banner

We have restructured our Literature Page – consolidating some of the pertinent material available on the web.

The NAABT Discussion Board now has over 1,740 members who have posted over 33,000 posts. The main educational site receives an average of 2,000 visitors a day. Although the discussion board is not a substitute for counseling, many have reported benefit from the anonymous peer based forum.

Disclosure:NAABT, Inc. has accepted funding from Reckitt Benckiser (Richmond, VA, pharmaceutical company that manufactures buprenorphine products) in the form of an “Unrestricted Educational Grant.” The grant is “unrestricted” so that there are no “strings” attached. NAABT, Inc. has complete control over how the funds are used, there are no restrictions on the content or mission of this site, and Reckitt has no control over the content of the site or NAABT’s activities. Reckitt is currently the only FDA approved maker of a buprenorphinebased product for addiction. NAABT, Inc. is not affiliated with Reckitt Benckiser. Click here to learn more about NAABT.

Click here to learn more about NAABT.

The National Alliance of Advocates for Buprenorphine Treatment is a non-profit organization formed to help people, in need of treatment, find treatment providers who are willing and able to treat opioid dependency in the privacy of a doctor’s office. Our website offers answers to frequently asked questions, a glossary, actual patient experiences, a discussion board, information on the history and treatments of opioid addiction, current news on the subject and more.

This newsletter is provided to keep you informed on matters relating to Buprenorphine Treatment. Please feel free to contact us at with feedback, suggestions, or perhaps you would like to contribute a story. Also feel free to photocopy or print as many as these newsletters as you wish for distribution.

To add yourself or someone you know to the mailing list, please either write us or email us at

The National Alliance of Advocates for Buprenorphine Treatment NAABT, Inc. • P.O. Box 333 • Farmington, CT 06034 Tel: 860.269.4390 • Fax: 860.269.4391 • email: